Meaningful real world data begins with the right insights,
the right partners, robust data and the patient’s voice
Patient Solutions
Real World Data
We design and implement Belgium-specific real world data pilots, identifying the right registries and clinical partners to generate high-quality insights. By integrating meaningful patient-reported outcomes, we support you in building a stronger, data-driven value proposition that is reflecting the patient impact.
Featured Services
Local Data
Importance of local data in supporting patient access in Belgium
Obtain Reimbursed Patient Access
We map the eligible patient population in Belgium using authoritative sources such as the BCR, CRM reports, and BNMDR register to define the epidemiological landscape. We conduct a thorough analysis of current clinical practice and unmet medical needs, drawing on registries, the Morse report, Farmanet data, and consensus statements. Based on these insights, we identify the optimal positioning for your drug within the Belgian treatment pathway. Our approach ensures alignment with local clinical standards and reimbursement requirements from the outset. The result is a clear, evidence-based strategy to bring your therapy to the patients who need it most. In Belgium’s strict regulatory environment, we act as the strategic bridge between industry, healthcare professionals, and third-party providers. Our expertise ensures your program adheres to pharma.be codes and GDPR standards while reducing the administrative burden on hospitals. By focusing on the patient journey, we help you transition from a product supplier to a trusted healthcare partner, delivering tangible value to both patients and payers.
Maintain Reimbursed Patient Access
Once reimbursement is secured, we help you navigate the ongoing uncertainties that can put access at risk. We monitor and model budgetary variables such as the number of patients treated, the drug's real-world positioning, and actual dosing patterns in clinical practice. We also track clinical uncertainties, including responder rates and long-term treatment outcomes, to keep your evidence base current and robust. Our proactive approach ensures that evolving data is translated into timely responses to payer requirements and contract obligations. This way, your drug remains reimbursed, accessible, and competitively positioned throughout its lifecycle.
Three step approach to an integrated
real world data strategy
We support you in the transitioning of RWD into a strategic asset—supporting sustained access, reinforcing competitive positioning, and strengthening trust among the different partners
(company, healthcare professionals, patients and payers).
Equally important is the timely translation of real‑world insights into accurate, strategically aligned responses for payers.
Improving access, enhancing outcomes, powered by real world data.
Create a coherent and convincing story
We translate RWD into a clear, locally grounded value narrative by integrating epidemiology, real-world clinical practice and the patient journey. This enables optimal product positioning and supports your transition from product supplier to trusted healthcare partner—delivering value for patients, clinicians, and payers.
02
Clinical development
We advise for the integration of parameters alongside clinical trials, ensuring the data generated are relevant, robust, and ready to support future reimbursement decisions.
04
Reimbursement maintenance
We ensure that potential data gaps are identified in time. Addressing clinical uncertainties is crucial to keep medicines reimbursed.
03
Reimbursed patient access
We translate clinical and real-world evidence into compelling reimbursement submissions, navigating complex requirements to secure timely access to your therapy.
Preclinical development
At the earliest stage, we lay the foundation for real-world evidence by identifying key endpoints, data sources, and evidence gaps that will shape the entire development strategy.
01
RWE planning
When to start?
Bringing a therapy to patients requires a seamless journey through preclinical and clinical development, where robust evidence is built from the ground up. Regulatory approval marks a critical milestone, validating the drug's safety and efficacy for use in real-world practice. Securing and maintaining reimbursed patient access is the final step, ensuring that proven therapies reach the patients who need them most.
Common Questions
Find answers to frequent inquiries about our support programs and enrollment process.
Enrollment is simple and flexible. Healthcare providers can enroll patients through our secure provider portal, by faxing a standard enrollment form, or via direct integration with major EHR systems. We also offer a dedicated phone line for real-time enrollment assistance.
Change the text and add your own content, including any information that is relevant to share. Then customize the font, size and scale to make it your own.
Change the text and add your own content, including any information that is relevant to share. Then customize the font, size and scale to make it your own. You can also
Change the text and add your own content, including any information that is relevant to share. Then customize the font, size and scale to make it your own. You can also drag
Ready to optimise patient access?
Connect with our experts to discuss how we can support
your strategic goals.